Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Q3 Revenues Plummet 58 Percent As 2003 Closure of Contract Proteomics Unit Takes Toll

NEW YORK , Nov. 4 (GenomeWeb News) - Large Scale Biology, owner of Predictive Diagnostics, today said that third-quarter revenue nosedived 58 percent, to $500,000 from $1.2 million one year ago.

The Vacaville, Calif.-based company did not break out figures for its wholly owned biomarker-company subsidiary.

 

LSB attributed the severe decline to the loss of $800,000 in revenues generated during the third quarter of 2003 by its Germantown, Md.-based contract proteomics business, which it closed last November ( see ProteoMonitor, GenomeWeb News' sister publication ).


The company spent $2.3 million on R&D in the period, down slightly from $2.7 million year over year.


Consequently, net losses for the third quarter narrowed to $4.2 million, or $.13 per share, from $4.3 million, or $.17 per share, in 2003.

 

The results do not include one full quarter of activity related to Predictive Diagnostics' agreement with PerkinElmer, which the companies announced in late September. Under the agreement, PerkinElmer will offer the Predictive Diagnostics' Biomarker Amplification Filter technology to complement its own prOTOF 2000 MALDI O-TOF mass spectrometer.


LSB ended the quarter with $3.9 million in cash and marketable securities.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.